Session

Immune activation and autoimmune disease (Posters)

RESULTS OF PILOT STUDY BEFORE STARTING OF HEPATITIS C SCREENING PROGRAM IN LITHUANIA
RESULTS OF PILOT STUDY BEFORE STARTING OF HEPATITIS C SCREENING PROGRAM IN LITHUANIA

ENRICHMENT OF VEILLONELLA SPECIES AND DEPLETION OF SULFATED SERUM BILE ACIDS IS CHARACTERISTIC OF PRIMARY SCLEROSING CHOLANGITIS INFLAMMATORY BOWEL DISEASE COMORBIDITY COMPARED TO INFLAMMATORY BOWEL DISEASE ALONE
ENRICHMENT OF VEILLONELLA SPECIES AND DEPLETION OF SULFATED SERUM BILE ACIDS IS CHARACTERISTIC OF PRIMARY SCLEROSING CHOLANGITIS INFLAMMATORY BOWEL DISEASE COMORBIDITY COMPARED TO INFLAMMATORY BOWEL DISEASE ALONE

ACUTE-ON-CHRONIC LIVER FAILURE: STILL AN UNRECOGNIZED SYNDROME?
ACUTE-ON-CHRONIC LIVER FAILURE: STILL AN UNRECOGNIZED SYNDROME?

ORTHOTOPIC LIVER TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS – DIFFERENT INDICATION GROUPS OUTCOMES, A SINGLE CENTRE EXPERIENCE
ORTHOTOPIC LIVER TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS – DIFFERENT INDICATION GROUPS OUTCOMES, A SINGLE CENTRE EXPERIENCE

TLR4, SIBO AND GUT MICROBIOTA IN PATIENTS WITH HYPERLIPIDEMIA
TLR4, SIBO AND GUT MICROBIOTA IN PATIENTS WITH HYPERLIPIDEMIA

FASTER DISEASE PROGRESSION OF PSC IN PATIENTS WITH ISOLATED DISEASE COMPARED TO PATIENTS WITH CONCOMITANT IBD: A RETROSPECTIVE MONOCENTRIC COHORT ANALYSIS
FASTER DISEASE PROGRESSION OF PSC IN PATIENTS WITH ISOLATED DISEASE COMPARED TO PATIENTS WITH CONCOMITANT IBD: A RETROSPECTIVE MONOCENTRIC COHORT ANALYSIS

NON-INVASIVE MARKERS OF DISEASE TO SUPPORT MANAGEMENT OF PAEDIATRIC PATIENTS WITH AUTOIMMUNE HEPATITIS
NON-INVASIVE MARKERS OF DISEASE TO SUPPORT MANAGEMENT OF PAEDIATRIC PATIENTS WITH AUTOIMMUNE HEPATITIS

2022 INTERNATIONAL AUTOIMMUNE HEPATITIS GROUP NON-RESPONSE CRITERIA IN AUTOIMMUNE HEPATITIS: A TOO EARLY ENDPOINT?
2022 INTERNATIONAL AUTOIMMUNE HEPATITIS GROUP NON-RESPONSE CRITERIA IN AUTOIMMUNE HEPATITIS: A TOO EARLY ENDPOINT?

IS PORTAL BILIOPATHY SYMPTOMATIC?
IS PORTAL BILIOPATHY SYMPTOMATIC?

NON-ALCOHOLIC STEATOHEPATITIS (NASH) OVERLAP WITH AUTOIMMUNE HEPATITIS IS MARKED BY SEVERE PORTAL INFLAMMATION AND WEIGHT REDUCTION APPEARS TO BE ASSOCIATED WITH BIOCHEMICAL AND FIBROSIS IMPROVEMENT
NON-ALCOHOLIC STEATOHEPATITIS (NASH) OVERLAP WITH AUTOIMMUNE HEPATITIS IS MARKED BY SEVERE PORTAL INFLAMMATION AND WEIGHT REDUCTION APPEARS TO BE ASSOCIATED WITH BIOCHEMICAL AND FIBROSIS IMPROVEMENT

NON-ALCOHOLIC STEATOHEPATITIS (NASH) OVERLAP WITH AUTOIMMUNE HEPATITIS IS MARKED BY SEVERE PORTAL INFLAMMATION AND WEIGHT REDUCTION APPEARS TO BE ASSOCIATED WITH BIOCHEMICAL AND FIBROSIS IMPROVEMENT
NON-ALCOHOLIC STEATOHEPATITIS (NASH) OVERLAP WITH AUTOIMMUNE HEPATITIS IS MARKED BY SEVERE PORTAL INFLAMMATION AND WEIGHT REDUCTION APPEARS TO BE ASSOCIATED WITH BIOCHEMICAL AND FIBROSIS IMPROVEMENT

Immune activation and autoimmune disease (Posters)  et al.

IS PORTAL BILIOPATHY SYMPTOMATIC?
IS PORTAL BILIOPATHY SYMPTOMATIC?

Immune activation and autoimmune disease (Posters)  et al.

2022 INTERNATIONAL AUTOIMMUNE HEPATITIS GROUP NON-RESPONSE CRITERIA IN AUTOIMMUNE HEPATITIS: A TOO EARLY ENDPOINT?
2022 INTERNATIONAL AUTOIMMUNE HEPATITIS GROUP NON-RESPONSE CRITERIA IN AUTOIMMUNE HEPATITIS: A TOO EARLY ENDPOINT?

Immune activation and autoimmune disease (Posters)  et al.

NON-INVASIVE MARKERS OF DISEASE TO SUPPORT MANAGEMENT OF PAEDIATRIC PATIENTS WITH AUTOIMMUNE HEPATITIS
NON-INVASIVE MARKERS OF DISEASE TO SUPPORT MANAGEMENT OF PAEDIATRIC PATIENTS WITH AUTOIMMUNE HEPATITIS

Immune activation and autoimmune disease (Posters)  et al.

FASTER DISEASE PROGRESSION OF PSC IN PATIENTS WITH ISOLATED DISEASE COMPARED TO PATIENTS WITH CONCOMITANT IBD: A RETROSPECTIVE MONOCENTRIC COHORT ANALYSIS
FASTER DISEASE PROGRESSION OF PSC IN PATIENTS WITH ISOLATED DISEASE COMPARED TO PATIENTS WITH CONCOMITANT IBD: A RETROSPECTIVE MONOCENTRIC COHORT ANALYSIS

Immune activation and autoimmune disease (Posters)  et al.

TLR4, SIBO AND GUT MICROBIOTA IN PATIENTS WITH HYPERLIPIDEMIA
TLR4, SIBO AND GUT MICROBIOTA IN PATIENTS WITH HYPERLIPIDEMIA

Immune activation and autoimmune disease (Posters)  et al.

ORTHOTOPIC LIVER TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS – DIFFERENT INDICATION GROUPS OUTCOMES, A SINGLE CENTRE EXPERIENCE
ORTHOTOPIC LIVER TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS – DIFFERENT INDICATION GROUPS OUTCOMES, A SINGLE CENTRE EXPERIENCE

Immune activation and autoimmune disease (Posters)  et al.

ACUTE-ON-CHRONIC LIVER FAILURE: STILL AN UNRECOGNIZED SYNDROME?
ACUTE-ON-CHRONIC LIVER FAILURE: STILL AN UNRECOGNIZED SYNDROME?

Immune activation and autoimmune disease (Posters)  et al.

ENRICHMENT OF VEILLONELLA SPECIES AND DEPLETION OF SULFATED SERUM BILE ACIDS IS CHARACTERISTIC OF PRIMARY SCLEROSING CHOLANGITIS INFLAMMATORY BOWEL DISEASE COMORBIDITY COMPARED TO INFLAMMATORY BOWEL DISEASE ALONE
ENRICHMENT OF VEILLONELLA SPECIES AND DEPLETION OF SULFATED SERUM BILE ACIDS IS CHARACTERISTIC OF PRIMARY SCLEROSING CHOLANGITIS INFLAMMATORY BOWEL DISEASE COMORBIDITY COMPARED TO INFLAMMATORY BOWEL DISEASE ALONE

Immune activation and autoimmune disease (Posters)  et al.

RESULTS OF PILOT STUDY BEFORE STARTING OF HEPATITIS C SCREENING PROGRAM IN LITHUANIA
RESULTS OF PILOT STUDY BEFORE STARTING OF HEPATITIS C SCREENING PROGRAM IN LITHUANIA

Immune activation and autoimmune disease (Posters)  et al.

Item 1 - 20 / 20
1